Abstract
Bivalirudin may be an effective anticoagulation alternative to heparin as anticoagulant agent in percutaneous peripheral interventions (PPI). We aimed to compare safety and efficacy of bivalirudin versus heparin as the procedural anticoagulant agent in patients undergoing PPI. We conducted an
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
